Amrutanjan Health Care Limited Market Cap ($155.76 Million)
Market Cap & Net Worth: Amrutanjan Health Care Limited (AMRUTANJAN)
Amrutanjan Health Care Limited market cap. Amrutanjan Health Care Limited (NSE:AMRUTANJAN) has a market capitalization of $155.76 Million (Rs14.40 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #17320 globally and #912 in its home market, demonstrating a 1.76% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Amrutanjan Health Care Limited's stock price Rs498.35 by its total outstanding shares 28900081 (28.90 Million). Also see AMRUTANJAN cash flow metrics for how efficiently the company converts equity into cash flow.
Amrutanjan Health Care Limited Market Cap History (2015–2026)
Amrutanjan Health Care Limited market cap history from 2015 to 2026. Data shows growth from $70.58 Million to $155.76 Million (8.01% CAGR). Check AMRUTANJAN stock price for real-time trading data and today's change.
Amrutanjan Health Care Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Amrutanjan Health Care Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore AMRUTANJAN shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.05x
Amrutanjan Health Care Limited's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.41x
Amrutanjan Health Care Limited's market cap is 0.41 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $78.47 Million | $1.87 Billion | $205.76 Million | 0.04x | 0.38x |
| 2017 | $97.13 Million | $2.22 Billion | $214.09 Million | 0.04x | 0.45x |
| 2018 | $87.24 Million | $2.22 Billion | $199.73 Million | 0.04x | 0.44x |
| 2019 | $133.48 Million | $2.52 Billion | $245.14 Million | 0.05x | 0.54x |
| 2020 | $152.95 Million | $2.61 Billion | $250.83 Million | 0.06x | 0.61x |
| 2021 | $286.96 Million | $3.32 Billion | $611.90 Million | 0.09x | 0.47x |
| 2022 | $219.07 Million | $4.05 Billion | $671.89 Million | 0.05x | 0.33x |
| 2023 | $186.19 Million | $3.80 Billion | $398.35 Million | 0.05x | 0.47x |
| 2024 | $225.86 Million | $4.21 Billion | $449.73 Million | 0.05x | 0.50x |
| 2025 | $208.95 Million | $4.51 Billion | $508.35 Million | 0.05x | 0.41x |
Competitor Companies of AMRUTANJAN by Market Capitalization
Companies near Amrutanjan Health Care Limited in the global market cap rankings as of November 4, 2026. Also see AMRUTANJAN total assets for a full breakdown of the balance sheet.
Key companies related to Amrutanjan Health Care Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Amrutanjan Health Care Limited (2015–2026)
Market capitalization of Amrutanjan Health Care Limited from 2015 to today. Between 2015 and today, Amrutanjan Health Care Limited's market cap moved from $70.58 Million to $ 155.76 Million, with a yearly change of 8.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs155.76 Million | -25.46% |
| 2025 | Rs208.95 Million | -7.49% |
| 2024 | Rs225.86 Million | +21.31% |
| 2023 | Rs186.19 Million | -15.01% |
| 2022 | Rs219.07 Million | -23.66% |
| 2021 | Rs286.96 Million | +87.62% |
| 2020 | Rs152.95 Million | +14.58% |
| 2019 | Rs133.48 Million | +53.01% |
| 2018 | Rs87.24 Million | -10.19% |
| 2017 | Rs97.13 Million | +23.78% |
| 2016 | Rs78.47 Million | +11.17% |
| 2015 | Rs70.58 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Amrutanjan Health Care Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $155.76 Million USD |
| MoneyControl | $155.76 Million USD |
| MarketWatch | $155.76 Million USD |
| marketcap.company | $155.76 Million USD |
| Reuters | $155.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Amrutanjan Health Care Limited
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn co… Read more